The US medical devices industry saw a drop of 25% in overall deal activity during November 2019, when compared with the last 12-month average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
A total of 60 deals worth $1.08bn were announced in November 2019, compared to the 12-month average of 80 deals.
Venture financing was the leading category in the month in terms of volume with 47 deals which accounted for 78.3% of all deals.
In second place was M&A with 11 deals, followed by private equity with two transactions, respectively accounting for 18.3% and 3.3% of overall deal activity in the country’s medical devices industry during the month.
In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $502.01m, while private equity and venture financing deals totalled $370.75m and $205m, respectively.
US medical devices industry deals in November 2019: Top deals
The top five medical devices industry deals accounted for 61.1% of the overall value during November 2019.
The combined value of the top five medical devices deals stood at $658.5m, against the overall value of $1.08bn recorded for the month.
The top five medical devices industry deals of November 2019 tracked by GlobalData were:
1) Clayton, Dubilier & Rice’s $205m private equity deal with Cynosure
3) Dare Bioscience’s $101.5m acquisition of Keratin Biosciences
5) ICU Medical’s acquisition of Pursuit Vascular for $75m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.